Tag: Cancer: Breast
Drug Combo Extends Survival in Advanced Breast Cancer
Benefit seen for addition of CDK4/6 inhibitor after progression of disease on endocrine therapy
Breast Cancer Mortality Rate Continues to Decline in the U.S.
Pace of decline slowed from 1.9 percent during 1998 to 2011 to 1.3 percent during 2011 to 2017
Higher Mortality Seen for Male Breast Cancer Patients
Clinical characteristics, undertreatment correlated with 63.3 percent excess mortality rate for men
Screening for Breast Cancer in Men Has Increased Over Time
Risk higher for older age, Ashkenazi descent, genetic mutations, and personal, first-degree family hx
Full Chemo Doses May Improve Survival in Breast Cancer
Maintaining full doses of chemo especially important early in the treatment course
Mammos May Not Benefit Elderly Women With Chronic Illness
Risk for death from other causes much higher than risk for breast cancer death with increasing comorbidity, age
USPSTF Advises Meds to Reduce Risk for Primary Breast Cancer
Offer risk-reducing meds to women at higher risk for breast cancer, low risk for adverse medication effects
Type and Timing of Menopausal HRT Affect Risk for Breast Cancer
Some excess risk persists for >10 years after ceasing therapy; magnitude varies with duration of use
FDA: Men Should Be Included in Breast Cancer Clinical Trials
Draft guidance that men be included in breast cancer trials issued by the FDA on Aug. 26
USPSTF Recommends Genetic Counseling for High BRCA Risk
But counseling not recommended for women without personal, family history, ancestry associated with BRCA mutations
